DOD. A. Okhobotov

D. A. Okhobotov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. A. Okhobotov has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rehabilitation options for patients with different types of urinary incontinence following transurethral surgery for benign prostatic hyperplasia

    by E. A. Meshcheriakova, D. Yu. Nevolnikov, O. Yu. Nesterova, A. A. Strigunov, M. Yu. Nikolaev, K. M. Yusupov, D. A. Okhobotov, N. I. Sorokin, A. A. Kamalov, Е. А. Мещерякова, et al.

    Introduction. Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for benign prostatic hyperplasia (BPH), while various endoscopic enucleation techniques are gaining increasing popularity. Despite the advantages of the minimally invasive transurethral approach, urinary incontinence (UI) remains one of the most significant and undesirable postoperative complications, potentially developing in the postoperative period and substantially impairing daily activities. Objective. To evaluate treatment options for UI following transurethral surgery for BPH. Materials & methods. A systematic review of the PubMed and Elibrary.ru databases was conducted for the period from 1999 to 2026 to identify all relevant studies. The search was limited to publications in Russian and English. Results. Following transurethral surgery for BPH, various UI types may develop, including urge, stress, and mixed incontinence. Reported rates of UI after transurethral procedures for BPH vary considerably across the literature, ranging from 0.5% to 60%. This wide variability reflects the lack of a unified definition and diagnostic approach to this complication. Management of urge urinary incontinence after transurethral surgery for BPH involves a multimodal approach, including anti-inflammatory and antibacterial agents, antimuscarinics, and beta-3 adrenergic receptor agonists; in more severe cases, intradetrusor botulinum toxin injections are employed. For stress urinary incontinence (SUI) associated with the transurethral approach in BPH, first-line therapy consists of pelvic floor muscle training (including biofeedback-guided exercises, magnetic or electrical stimulation). In more severe cases, surgical interventions are considered, such as sling placement or artificial urinary sphincter implantation. Conclusion. Pelvic floor muscle training represents one of the most promising treatment modalities for UI following transurethral surgery for BPH. However, further research is needed to clarify optimal rehabilitation strategies, as current evidence remains insufficient to fully assess the efficacy, safety, and potential interactions of different treatment approaches for post-transurethral incontinence in men.

  • Prevalence and prediction of urinary incontinence after transurethral surgery for prostatic hyperplasia: evaluation of different approaches

    by E. A. Meshcheriakova, R. R. Neftulaev, O. Yu. Nesterova, A. A. Strigunov, M. Yu. Nikolaev, K. M. Yusupov, D. A. Okhobotov, N. I. Sorokin, A. A. Kamalov

    Introduction . Transurethral resection of the prostate (TURP) has historically been regarded as the gold standard surgical treatment for benign prostatic hyperplasia (BPH), although over the past two decades the spectrum of transurethral procedures has expanded substantially with the introduction of various enucleation techniques. Despite the favourable safety profile of contemporary technologies, urinary incontinence (UI) remains one of the most clinically significant complications following transurethral surgery for BPH. Objective . To summarise current data on the incidence and classification of different forms of UI after transurethral procedures for BPH; to analyse key risk factors, and to critically appraise existing predictive models and nomograms, with a view to outlining prospects for their further refinement and clinical implementation. Materials & methods . A literature search was performed in the PubMed and Elibrary.ru databases for the period from 1999 to 2026, restricted to publications in Russian and English. Results . A central challenge in studying postoperative UI is the absence of a single standardised definition, with clinical studies employing both subjective measures (patient‑reported symptoms and validated questionnaires such as ICIQ‑SF, IPSS, UCLA‑PCI) and objective metrics (pad counts and 24‑hour pad tests). The principal mechanism of stress UI is injury to the external urethral sphincter at the prostatic apex and verumontanum due to mechanical trauma during enucleation and urethral dilation, whereas urgency UI is attributed to pre‑existing detrusor overactivity from chronic obstruction and to postoperative inflammation and bladder irritation, including potential thermal effects. Proposed risk factors for UI include age, body mass index, operative technique, prostate volume and growth pattern, urethral anatomy, urodynamic parameters, and surgeon experience. Based on these predictors, several prognostic models and nomograms have been developed in recent years to enable individualised assessment of postoperative UI risk and to improve preoperative counselling and surgical decision‑making. Conclusion . Reported UI rates vary widely due to heterogeneity in definitions and assessment methods, highlighting the need for user‑friendly tools that facilitate implementation of predictive models in routine practice.

  • Open Access

    Cancer-associated fibroblasts and clinical and morphological features of prostate cancer

    by O. Yu. Nesterova, N. A. Oleynikova, M. G. Varentsov, I. A. Zhestkov, A. A. Strigunov, D. A. Okhobotov, П. Г. Мальков, A. A. Kamalov

    Introduction. In recent years, researchers have been paying special attention to the structure of the tumor microenvironment, which is assumed to be able to modulate the tumor behavior due to various paracrine factors and, thereby, act as a marker of the course and prognosis of prostate cancer (PCa). One of the components of the tumor microenvironment are cancer-associated fibroblasts (CAFs). Fibroblast activation protein (FAP) and plateletderived growth factor receptors α and β (PDGFR α and β) can be used as markers of CAFs. Objective. To evaluate the association between the clinical and morphological features of PCa and CAFs markers, FAP and PDGFRα + β. Materials & methods. The study used surgical material obtained from 34 patients with PCa. The age of the patients ranged from 52 to 77 years (mean age 64.1). The surgical material was stained with CAFs – FAP and PDGFRa + β markers. Subsequently, the relationship between these markers and the clinical and morphological features of PCa was analyzed using the RStudio software in the R programming language. Results. A higher Gleason grade in the presence of FAP was noted: in 81.3% of cases, PCa was classified as Gleason 4 + 3 = 7 and higher, while in the absence of FAP, only 33.3% of tumors belonged to this category (p=0.014). In addition, patients with FAP were significantly more likely to have lymphatic invasion, which was detected in 43.8% of cases, while in the absence of FAP it was detected only in 5.6% (0.015). In the presence of FAP, patients were more likely to have a lesion of the prostate according to MRI, and lymph nodes were also more often affected (31.2% and 5.6%), however, this parameter had a borderline significance level (p = 0.078). With moderate/high PDGFRa + β expression, a higher Gleason grade was noted: in 80.0% of cases, PCa was classified as Gleason 4 + 3 = 7 and higher, while with no/ weak PDGFRa + β expression, only 36.8% of tumors belonged to this category (p = 0.030). In patients with moderate/ high PDGFRa + β expression, there was a more frequent probability of involvement of lymph nodes in the process (according to the MSKCC nomogram) and more likely to have lesions according to MRI at the borderline significance level of these parameters (p = 0.097 and p = 0.063, respectively). Conclusion. The presence and severity of expression of stromal CAFs markers are associated with unfavorable clinical and morphological features of prostate cancer with a higher Gleason grade, more frequent lesions on MRI and the presence of invasion into the lymphatic vessels.

  • Open Access

    Viral microbiome of prostate tissue in benign prostatic hyperplasia and prostate cancer

    by A. A. Kamalov, L. M. Mikhaleva, V. K. Karpov, D. A. Okhobotov, T. B. Takhirzade, A. M. Pshikhachev, O. Yu. Nesterova, B. M. Shaparov, A. A. Strigunov, V. V. Pechnikova, et al.

    Aim. To evaluate the incidence of various viruses in prostate tissue in benign prostatic hyperplasia (BPH) and prostate cancer (PCa).Materials and methods. The study included 145 patients who were operated on for BPH (n = 79) or PCa (n = 66) in the period between 2019 and 2023. Real-time polymerase chain reaction was performed in the obtained samples of surgical material to determine the presence of human papillomavirus (HPV), herpes simplex viruses type 1 and 2, cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes virus type 6 (HHV-6).Results. Mean age of patients was 68.2 years. Viruses in prostate tissue were found in 40.7 % of patients in the total cohort: in 35.4 % of patients with BPH and in 47.0 % of patients with PCa (p = 0.159). The most common virus detected in the total cohort of patients was EBV which was found in 18.6 % of patients: in 16.5 % of patients with BPH and in 21.2 % of patients with PCa (p = 0.464). The second most common was HHV-6 (9.0 % of patients of the total cohort: 19.7 % of patients with PCa and in 0 % with BPH, p 0.001), and the third was CMV (7.6 % of patients: 2.5 % of patients with BPH and 13.6 % of patients with PCa, p = 0.027). When combining all HPV types, the prevalence of HPV was 10.3 %, but individual subtypes were found in isolated cases and their incidence in the total cohort did not exceed 2.1 %. The incidence of HPV (all types) was 16.5 % in patients with BPH and 3.0 % in patients with PCa (p = 0.018).Conclusion. In patients with prostate diseases, almost half of the cases have viral infection localized in the prostate tissue. CMV and HHV-6 are the most common in patients with PCa. The latter was not found in patients with BPH. EBV is equally represented among patients with BPH and PCa.


  • Open Access

    Consistency between Gleason score of prostate biopsy and radical prostatectomy: predictors of increased tumour grading

    by O. Yu. Nesterova, M. G. Varentsov, N. A. Oleynikova, A. A. Strigunov, I. A. Zhestkov, D. A. Okhobotov, D. M. Kamalov, N. I. Sorokin, A. A. Kamalov

    Introduction. Gleason grading is one of the key parameters for determining the prostate cancer (risk group after receiving the results of a prostate biopsy in addition to the level of prostate-specific antigen (PSA). However, an important clinical issue arises from changes in this grading following radical surgery. In some cases, such discrepancies in data can lead to a shift in patient management tactics from radical surgery to active follow-up recommended for patients with low cancer risk.Objective. To assess the consistency of the results of prostate biopsy and radical prostatectomy with an assessment of possible predictors of increased tumor Gleason grading.Materials & methods. Between 2019 and 2021, 193 patients with prostate cancer were selected for treatment at the Medical Centre of Moscow State University. Of these, 139 patients were chosen for the final analysis of Gleason tumour grading consistency after biopsy and radical prostatectomy.Results. The results of prostate biopsy and radical prostatectomy were comparable in 54.7% of patients (n = 76), while the remaining 45.3% (n = 63) showed a change in Gleason gradaing after radical prostatectomy: 29.5% (n = 41) patients showed an increased gradation, and 15.8% (n = 22) — decrease. Most often, the data were consistent for patients with a Gleason score 7: 63.6% for 3 + 4 = 7 and 57.9% for 4 + 3 = 7. The highest percentage of graduation increase was observed for patients from the group 3 + 3 = 6 and amounted to 48%. Cohen's kappa value was 0.351 (p < 0.001), indicating poor consistency between the results of the two studies. The total number of biopsies was associated with an increase in Gleason score after radical prostatectomy (OR = 0.816; 95% CI = 0.680 – 0.978). For example, the odds of Gleason tumour grading decreases by 18.4% when the number of biopsy specimens per unit increasesConclusion. The concordance of Gleason grading of prostate cancer after prostate biopsy and radical prostatectomy remains poor. The only predictor of improved concordance is the biopsy count, thereby reflecting biopsy quality and encouraging clinicians to move away from sextant biopsies to systematic and targeted biopsies. Increasing the consistency of results can provide more accurate staging and classification of patients according to cancer risk, thereby influencing future management.

  • Open Access

    Changes of serum osteoprotegerin level in recurrent urolithiasis

    by A. V. Savilov, M. Jain, A. S. Tivtikyan, M. E. Kotsepuga, D. M. Anokhin, L. M. Samokhodskaya, D. A. Okhobotov, S. P. Shershnev, A. A. Kamalov, М. Джайн

    Introduction.In our earlier research on the role of genetic factors in the development of recurrent urolithiasis, a significant relationship was found between the presence of single-nucleotide polymorphism rs3134057 in the osteoprotegerin (OPG) gene and the development of this disease. The above-mentioned single-nucleotide polymorphism is intronic, therefore, it is unable to involve the structure and functions of the OPG but to affect its expression. Thus, the study of serum OPG level may have diagnostic significance in recurrent urolithiasis.Objective.To study the relationship of serum OPG level with the presence of recurrent urolithiasis, as well as the effect of single nucleotide polymorphism rs3134057 on the OPG level.Materials & methods.One hundred and fifteen volunteers were included in the study from January 2021 to January 2022. Of the 115 participants, 45 (main group #1) were diagnosed with recurrent urolithiasis and localisation of the main stone in one of the ureters, 28 participants (main group #2) had previously suffered a single episode of acute renal colic followed by surgical treatment or stone self-discharge and were stone-free at the time of the study. Forty-two control group respondents were free of urolithiasis, including family history of urolithiasis. The serum OPG levels was determined by enzyme immunoassay using the Human OPG ELISA kit ab100617 ("Abcam plc", Cambridge, UK) according to the manufacturer's advice.Results.The analysis revealed that the serum OPG levels were significantly higher in the main group #1 than in the control group (median: 9.02 vs. 3.635, p = 0.012). When analyzing the relationship between the concentration of OPG in serum and the AA + AG genotype versus GG according to rs3134057 of the OPG gene, no statistically significant difference was found (p > 0.05). The same result was obtained when comparing groups with AA vs. AG vs. GG genotypes (p > 0.05).Conclusion.The present study showed that an increased serum OPG level in patients with recurrent urolithiasis may indicate the presence of a relapse of the disease. Further study in large samples will finally confirm the significance of OPG as a marker of relapse, including in genetically determined forms.

  • Open Access

    Non-invasive electromagnetic detection of prostate cancer: efficiency analysis

    by M. E. Chaliy, E. V. Afanasyevskaya, A. S. Amirkhanyan, A. A. Strigunov, A. M. Kadysheva, E. V. Kolygina, A. S. Shurygina, A. S. Tivtikyan, A. V. Kadrev, V. K. Dzitiev, et al.

    Introduction. Early diagnosis of cancer is one of the most important international strategies. Malignant and healthy tissues differ in the interaction with electromagnetic waves. Pilot studies show a potential perspective for non-invasive analysis of electromagnetic anisotropy in biological tissues.Objective. To assess the diagnostic importance of the electromagnetic detection of prostate cancer (PCa) within the prospective study.Materials & methods. One hundred and twenty-four patients were included to undergo a prostate biopsy, transurethral prostate resection, or radical prostatectomy. The investigators did not have information on their clinical details. Research technique: the probe was applied to the perineal region, turning it in three planes. A reduction of the 465 MHz band below a threshold was fixed and was considered suspect for PCa. The results of electromagnetic evaluation were compared with the findings of a pathomorphological study after biopsy or surgery.Results. Fourty-seven true-positive and 21 true-negative results were detected, 20 false-negative and 46 false-positive (follow-up group as potentially true-positive group). The overall sensitivity was 82%, specificity – 31%. The positive and negative predictive values were 73% and 62%, respectively. The accuracy of the method was 54%.Conclusion. Early PCa stage could be a reason for many false-positive results and low specificity, as a result. PCa detection is significantly reduced with lesions less than 3 mm, therefore patients with false-positive results were placed in the follow-up group. Patients’ examination with the TRIMprob TM («Galileo Avionica» SpA, Torino, Italy) could increase the early PCa detection at the screening. The research is currently ongoing.

  • Open Access

    The risk of developing autonomic dysreflexia during urodynamic testing in patients after spinal cord injury

    by A. A. Kamalov, D. A. Okhobotov, M. E. Chaly, M. V. Frolova, I. V. Khutoroi, R. V. Salyukov

    Introduction. Autonomic dysreflexia (AD) is a life-threatening dangerous condition in patients with spinal cord injury (SCI) above the T6 segment level. It is characterized by a sudden rise in systolic blood pressure more than 20 mmHg, and unpredictable reactions from the autonomic nervous system. An episode of autonomic dysreflexia can lead to several cardiovascular catastrophes – heart attack and/or acute cerebrovascular accident up to a lethal outcome. Currently, there is no diagnostic algorithm and no way to determine risk factors for the occurrence of autonomic dysreflexia.Objective. To search for the most informative diagnostic criteria for autonomic dysreflexia in patients with spinal cord injury.Materials and methods. The study included 40 patients with SCI above the T6 segment. Depending on the SCI degree, two groups were distinguished. Group 1 (n = 14) included patients with complete spinal cord injury, advising category A on the ASIA scale. Group 2 (n = 26) included patients with incomplete spinal cord injury, classified as ASIA-B, C, D. For a preliminary assessment of the risk factors for the development of AD, an ADFSCI questionnaire was used, then a urodynamic study was conducted with simultaneous registration of systolic / diastolic blood pressure (SBP / DBP), and heart rate, which confirmed or denied the presence of AD in patients.Results. According to the ADFSCI questionnaire, most patients showed a high degree of severity of autonomic disorders, suggesting the presence of AD. Subsequently, this assumption was confirmed by the results of a urodynamic testing with simultaneous monitoring of SBP / DBP and heart rate. When comparing the groups, statistically significant differences were found in the parameters of the ADFSCI questionnaire, as well as in the indicators of SBP / DBP (at the points of maximum detrusor pressure and when the cystometric capacity is reached).Conclusion. The obtained results allow us to draw conclusions about the high incidence of AD in patients with SCI above the T6 segment and the need for a preliminary assessment of the risks of developing this condition based on the ADFSCI questionnaire before conducting a urodynamic study. Considering the possible complications of AD, the urodynamic testing should be accompanied by continuous monitoring of the indicators of the cardiovascular system.


  • Open Access

    Androgen deprivation therapy and hormonal status in men with COVID-19

    by A. A. Kamalov, D. A. Ohobotov, O. Yu. Nesterova, A. A. Strigunov, A. S. Tivtikyan

    Severe course of COVID-19 among men compared to the female led to a detailed study of the hormonal status of men with COVID-19. The earliest works about this focused on the incidence and severity of COVID-19 depending on the intake of androgen deprivation therapy. At the same time, different classes of androgen deprivation therapy have different effects on androgen concentration that was not always considered in the analysis. In this regard, we conducted a review of the available literature data with a targeted study of works that included androgen deprivation therapy with a unidirectional effect on the concentration of male sex hormones. In addition, we conducted a review of studies focused on the relationship between COVID-19 and androgens (testosterone and dihydrotestosterone).

  • Open Access

    The role of genetic factors in the development of recurrent urolithiasis

    by A. V. Savilov, M. Jain, D. M. Anokhin, M. E. Kotsepuga, A. S. Tivtikyan, L. M. Samokhodskaya, D. A. Okhobotov, E. V. Afanasyevskaya, V. N. Mamedov, A. S. Shurygina, et al.

    Introduction. Urolithiasis is a polyethylological disease of the urinary system. Epidemiological data on urolithiasis is disappointing: over the past 30 years, the number of patients with urolithiasis has increased by 48.57%, and the mortality rate has increased by 17.12%. Single nucleotide polymorphisms in various genes can influence the risk of development and recurrence of this disease. Early diagnosis of a patient's genetic predisposition to primary or recurrent urolithiasis is important for the effective prevention of urolithiasis.Objective. To explore the association of SNP (Single Nucleotide Polymorphism) rs3134057 (TNFRS11B), rs851982 (ESR1), rs1540339 (VDR), rs2202127 (CASR), rs526906 (KL) with the development of recurrent urolithiasis.Materials and methods. The observed group consisted of 96 patients with a single-sided ureteral stone, of whom 45 had recurrent urolithiasis; the control group consisted of 51 volunteers. Venous blood samples were collected from all participants, DNA was extracted from the blood and analyzed for each SNP studied by real-time polymerase chain reaction. We analyze the data obtained on genotype and presence or absence of urolithiasis in the participants using a binomial logistic regression model.Results. An association was found between the presence of SNP rs3134057 in the TNFRS11B gene (odds ratio (OR), 1.92; confidence interval (CI): 1.05-3.52; p = 0.031) and the development of recurrent urolithiasis.Conclusion. The association of rs3134057 with urolithiasis relapse leads us to investigating the effect of this SNP on serum osteoprotegerin levels, a product of the TNFRS11B gene.